OBI Pharma (Taiwan) Today
| 4174 Stock | TWD 63.30 0.30 0.48% |
Performance0 of 100
| Odds Of DistressLess than 37
|
OBI Pharma is selling for under 63.30 as of the 26th of November 2024; that is 0.48% up since the beginning of the trading day. The stock's lowest day price was 63.2. OBI Pharma has about a 37 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for OBI Pharma are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of December 2022 and ending today, the 26th of November 2024. Click here to learn more.
OBI Pharma, Inc., a bio-pharma company, develops and licenses novel therapeutic agents for unmet medical needs against cancer in Taiwan and internationally. The company was founded in 2002 and is based in Taipei, Taiwan. OBI PHARMA operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange.. The company has 228.95 M outstanding shares. More on OBI Pharma
Moving together with OBI Stock
Moving against OBI Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
OBI Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. OBI Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding OBI Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | Michael Chang |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
OBI Pharma (4174) is traded on Taiwan OTC Exchange in Taiwan and employs 48 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 17.7 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate OBI Pharma's market, we take the total number of its shares issued and multiply it by OBI Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. OBI Pharma operates under Healthcare sector and is part of Biotechnology industry. The entity has 228.95 M outstanding shares.
OBI Pharma has accumulated about 3.57 B in cash with (1.06 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 17.92.
Check OBI Pharma Probability Of Bankruptcy
Ownership AllocationOBI Pharma owns a total of 228.95 Million outstanding shares. OBI Pharma has substantial amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the entity is less than the current market value, you may not be able to make money on it.
Check OBI Ownership Details
OBI Pharma Risk Profiles
Although OBI Pharma's alpha and beta are two of the key measurements used to evaluate OBI Pharma's performance over the market, the standard measures of volatility play an important role as well.
OBI Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in OBI Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
| All Next | Launch Module |
OBI Pharma Corporate Directors
| Jerry Fong | Independent Director | Profile | |
| LungYeh Cho | Director | Profile | |
| Taychang Wang | Independent Director | Profile | |
| ChungMing Chang | Independent Director | Profile |
Additional Tools for OBI Stock Analysis
When running OBI Pharma's price analysis, check to measure OBI Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OBI Pharma is operating at the current time. Most of OBI Pharma's value examination focuses on studying past and present price action to predict the probability of OBI Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OBI Pharma's price. Additionally, you may evaluate how the addition of OBI Pharma to your portfolios can decrease your overall portfolio volatility.